Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Total Current Liabilities (2016 - 2025)

Bio Key International's Total Current Liabilities history spans 16 years, with the latest figure at $3.0 million for Q3 2025.

  • For Q3 2025, Total Current Liabilities fell 49.5% year-over-year to $3.0 million; the TTM value through Sep 2025 reached $3.0 million, down 49.5%, while the annual FY2024 figure was $4.6 million, 41.71% up from the prior year.
  • Total Current Liabilities for Q3 2025 was $3.0 million at Bio Key International, down from $3.5 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $6.3 million in Q2 2023 and bottomed at $1.6 million in Q1 2021.
  • The 5-year median for Total Current Liabilities is $3.5 million (2022), against an average of $3.9 million.
  • The largest annual shift saw Total Current Liabilities plummeted 60.75% in 2021 before it skyrocketed 172.88% in 2022.
  • A 5-year view of Total Current Liabilities shows it stood at $2.0 million in 2021, then soared by 172.88% to $5.5 million in 2022, then tumbled by 41.1% to $3.2 million in 2023, then skyrocketed by 41.71% to $4.6 million in 2024, then plummeted by 34.91% to $3.0 million in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Total Current Liabilities are $3.0 million (Q3 2025), $3.5 million (Q2 2025), and $3.5 million (Q1 2025).